Brain and Liver Dual‐Targeting Oridonin Nanoparticles to Enhance Aβ Clearance for Alzheimer's Disease Therapy
ABSTRACT The brain and liver are both critical organs involved in the pathogenesis of Alzheimer's disease (AD), particularly in the modulation of amyloid‐beta (Aβ) metabolism and neuroinflammation. Based on this, a multifunctional nanodrug delivery system, termed OAF, was developed by encapsulating...
Gardado en:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2026-06-01
|
| Series: | Advanced Science |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/advs.202523458 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
